Skip to main content
SpringerLink
Log in

Chromosome 17 Aneusomy is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Aberrations of chromosome 17 are common in breast cancer. Fluorescence in situ hybridization (FISH) enables gene or chromosome copy number to be assessed in situ in archival tissues and related to morphology and clinical outcome. In this study direct labeled DNA probes for the chromosome 17 alpha satellite and the HER2/neu gene were applied simultaneously to 5 micron sections of 214 formalin-fixed paraffin-embedded invasive primary breast carcinomas. A high proportion (54%) of invasive breast carcinomas displayed aneusomy of chromosome 17. Polysomy 17 correlated with multiple copies of HER2/neu (p = <0.001), but not with HER2/neu amplification. Eighty-six patients without HER2/neu amplification had aneusomy 17. Fifty-eight of the 86 patients that had aneusomy 17 had high HER2/neu copy number. Twelve patients with normal copy number for chromosome 17 had amplification of HER2/neu and 30 patients had amplification of HER2/neu with aneusomy 17. Aneusomy 17 was associated with grade 3 carcinoma (p = 0.008), ER negativity (p = 0.0032) and a Nottingham prognostic index of greater than 5.4 (p = 0.039) but was not associated with survival by univariate analysis. In conclusion, the determination of chromosome 17 copy number should be incorporated in assessment of HER2/neu status, as this will give an accurate measure of amplification of HER2/neu and may also be helpful in determining suitability for breast carcinoma trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pinder SE, Ellis IO, Elston CW: Prognostic factors in primary breast carcinoma. J Clin Pathol 48: 981-983, 1995

    Google Scholar 

  2. Written on behalf of the Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research: Can biological markers improve the management of breast cancer patients? Br J Cancer 82: 1625-1626, 2000

    Google Scholar 

  3. Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996

    Google Scholar 

  4. Dowsett M, Cooke T, Ellis I, Gullick WJ, Gusterson B, Mallon E, Walker R: Assessment of HER2 status in breast cancer: why when and how? Eur J Cancer 36: 170-176, 2000

    Google Scholar 

  5. McManus DT, Patterson AH, Maxwell P, Hamilton PW, Anderson NH, Caughley LM, Toner PG: Interphase cytogenetics of chromosomes 11 and 17 in fine needle aspirates of breast cancer. Hum Pathol 30: 137-144, 1999

    Google Scholar 

  6. Sigurdsson S, Bödvarsdottir SK, Anamthawat-Jonsson K, Steinarsdottir M, Jonasson JG, ögmundsdottir HM, Eyfjörd JE: p53 abnormality and chromosomal instability in the same breast tumor cells. Cancer Genet Cytogenet 121: 150-155, 2000

    Google Scholar 

  7. Adeyinka A, Mertens F, Idvall I, Bondeson L, Pandis N: Multiple polysomies in breast carcinomas: preferential gain of chromosomes 1, 5, 6, 7, 12, 16, 17, 18, and 19. Cancer Genet Cytogenet 111: 144-148, 1999

    Google Scholar 

  8. Herrington CS, Leek RD, McGee JO'D: Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes. J Pathol 176: 353-359, 1995

    Google Scholar 

  9. Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakamura Y, Yakahashi T, Abe T, Inazawa J: Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 77: 2064-2069, 1995

    Google Scholar 

  10. Tsukamoto F, Miyoshi Y, Koyama H, Watatani M, Sasa M, Shiba E, Takami S, Inazawa J, Noguchi S: Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: application to the preoperative diagnosis of breast carcinoma. Cancer Cytopathol 90: 373-378, 2000

    Google Scholar 

  11. Bartlett JMS, Going JJ, Mallon EA, Watters AD, Reeves JR, Stanton P, Richmond J, Donald B, Ferrier R, Cooke TG: Evaluating HER2 amplification and overexpression in breast cancer. J Pathol 193: 1-7, 2001

    Google Scholar 

  12. Watters AD, Ballantyne SA, Going JJ, Grigor KM, Bartlett JMS: Aneusomy of chromosomes 7 and 17 predicts recurrence of transitional cell carcinoma of the urinary bladder. Br J Urol 85: 42-47, 2000

    Google Scholar 

  13. Bartlett JMS, Watters AD, Ballantyne SA, Going JJ, Grigor KM, Cooke TG: Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder? Br J Cancer 77: 2193-2198, 1998

    Google Scholar 

  14. Reeves JR, Going JJ, Smith G, Cooke TG, Ozanne BW, Stanton PD: Quantitative radioimmunohistochemical measurements of p185 (erbB-2) in frozen tissue sections. J Histochem Cytochem 44: 1251-1259, 1996

    Google Scholar 

  15. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersso T, Ikdahl T, Maria A, Caligo A, Lidereau R, Lindblom A, Seit S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon Y, Scherneck S, Barkardottir R, Borresen-Dale A, Eyfjord J, Theillet C, Thompson AM, Devilee P, Larsson C: Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res 58: 1004-1012, 1998

    Google Scholar 

  16. Botti C, Pescatore B, Mottolese M, Sciarretta F, Greco C, Di Filippo F, Gandolfo GM, Cavaliere F, Bovani R, Varanese A, Cianciulli AM: Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study. J Am Coll Surg 190: 516-525, 2000

    Google Scholar 

  17. Micale MA, Visscher DW, Gulino SE, Wolman SR: Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 25: 29-35, 1994

    Google Scholar 

  18. Wolman SR: Fluorescence in situ hybridization: a new tool for the pathologist. Hum Pathol 25: 586-590, 1994

    Google Scholar 

  19. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G: Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/ genotype correlation. Genes Chromos Cancer 25: 195-204, 1999

    Google Scholar 

  20. Dillon DA, Howe CL, Bosari S, Costa J: The molecular biology of breast cancer: accelerating clinical applications. Crit Rev Oncogen 9: 125-140, 1998

    Google Scholar 

  21. Murphy DS, McHardy P, Coutts J, Mallon EA, George WD, Kaye SB, Brown R, Keith WN: Interphase cytogenetic analysis of erbB2 and topoIIalpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Int J Cancer 64: 18-26, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glasgow Royal Infirmary, University Departments of Surgery & Pathology, Glasgow, Scotland, UK

    A.D. Watters, J.J. Going, T.G. Cooke & J.M.S. Bartlett

Authors
  1. A.D. Watters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J.J. Going
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T.G. Cooke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.M.S. Bartlett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watters, A., Going, J., Cooke, T. et al. Chromosome 17 Aneusomy is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma. Breast Cancer Res Treat 77, 109–114 (2003). https://doi.org/10.1023/A:1021399923825

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021399923825

Search

Navigation